STIM 0.75 (-57.87%)
US64131A1051Medical Diagnostics & ResearchDiagnostics & Research

Neuronetics (STIM) Competitor Comparison

We are evaluating the key criteria listed to compare Neuronetics (STIM) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - STIM ranking 36 / 58

These are the competitors of Neuronetics in the industry Diagnostics & Research ranked by linearity 10 years
1. Neogen NEOG
685.85
2. Guardant Health GH
684.73
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Inotiv NOTV
17.87
5. Illumina ILMN
11.92
6. Olink Holding OLK
8.11
7. National Research NRC
7.67
8. Myriad Genetics MYGN
7.6
9. Pacific Biosciences of California PACB
6.01
10. Global Cord Blood CO
5.67
11. DarioHealth DRIO
4.86
12. Sotera Health SHC
4.5
13. Sera Prognostics SERA
3.82
14. Syneos Health SYNH
3.71
15. Anixa Biosciences ANIX
3.32
16. Co-Diagnostics CODX
3.26
17. Fulgent Genetics FLGT
3.07
18. Enzo Biochem ENZ
2.84
19. Psychemedics PMD
2.74
20. Qiagen QGEN
2.71
21. Bioventus BVS
2.7
22. Twist Bioscience TWST
2.53
23. Exagen XGN
2.32
24. Aspira Womens Health AWH
2.28
25. MDxHealth MDXH
2.15
26. NeoGenomics NEO
2.12
27. Meridian Bioscience VIVO
2.1
28. Exact Sciences EXAS
2.04
29. Biodesix BDSX
2.02
30. MaxCyte MXCT
1.95
31. Prenetics Global PRE
1.85
32. Personalis PSNL
1.84
33. bioAffinity Technologies BIAF
1.78
34. CareDx CDNA
1.73
35. Organovo Holdings ONVO
1.66
36. Neuronetics STIM
1.64
37. Trinity Biotech TRIB
1.59
38. SeqLL SQL
1.48
39. Quest Diagnostics DGX
1.44
40. Charles River Laboratories CRL
1.35
41. Laboratory Corp of America Holdings LH
1.33
42. Interpace Biosciences IDXG
1.2
43. PerkinElmer PKI
1.15
44. DexCom DXCM
1.12
45. Precipio PRPO
1.09
46. Waters WAT
0.97
47. Agilent Technologies A
0.85
48. IQVIA Holdings IQV
0.62
49. Heska HSKA
0.52
50. Mettler-Toledo MTD
0.48
51. IDEXX Laboratories IDXX
0.42
52. RadNet RDNT
0.42
53. Natera NTRA
0.41
54. Thermo Fisher Scientific TMO
0.41
55. Lantheus Holdings LNTH
0.37
56. Danaher DHR
0.34
57. Medpace Holdings MEDP
0.3
58. Icon ICLR
0.25

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.